Food Sensitivity Testing 101: Supporting Clients with Inflammation and Gut Issues

On Wednesday, October 8th, FMCA hosted a special Ask the Expert webinar with James White, founder and CEO of KBMO Diagnostics, the company behind the patented Food Inflammation Test (FIT Test). In this exclusive conversation with FMCA faculty member Monique Class, James explored how food sensitivity testing can support personalized coaching approaches to reduce inflammation and promote better gut health.

Unlike traditional food sensitivity tests, the FIT Test measures both immune reactivity and inflammation markers, providing deeper insight into how certain foods may contribute to chronic symptoms. James explained how this testing can help clients make more informed dietary choices, uncover hidden drivers of inflammation, and feel supported with tools like personalized meal plans and a patient app.

Whether you work with clients on digestive concerns, autoimmune conditions, or overall lifestyle change, this session offered science-backed knowledge and practical tools that coaches can apply through the coaching relationship.

In this interactive session, James White and Monique Class explored:

The difference between food sensitivity exposure and inflammation, and why it matters
How the FIT Test measures IGG1–4 and C3d, plus key gut health markers like zonulin and candida
The role of gut permeability and immune reactivity in driving chronic health conditions
How health coaches can support clients using personalized nutrition and lifestyle strategies

Watch the Replay

Food Sensitivity Testing 101: Supporting Clients with Inflammation and Gut Issues, With James White, CEO of KBMO Diagnostics

Meet the Guest

James White

KBMO Diagnostics

Over 30 years of Diagnostic and Pharmaceutical experience working globally, launching a range of innovative products to help with cardiovascular disease, ranging from multiplex molecular diagnostic instruments and assays through to point-of-care blood gas solutions.

James acquired the developer of the patented FIT (Food Inflammation Test), which is the first assay to simultaneously identify IGG1-4 and C3d, inflammation markers, for 176 foods, colorings, and additives. The ability to help reduce inflammation by personalizing a patient’s diet has the promise to reduce symptoms in cardiovascular, diabetes, IBS, and other autoimmune diseases, as well as the opportunity to aid in weight loss. The company has expanded the product range to include FIT 22, FIT 132, and FIT 176 assays and recently launched the Gut Barrier Panel.

The company has grown from 5 to just over 10,000 providers ordering the test in the USA and internationally through our distribution and Laboratory partners in Asia, Europe, and Latin America. The company’s facilities include an ISO- and FDA-registered manufacturing facility, 2 CLIA High Complexity laboratories, Sales and Marketing, and Logistics Capabilities. During the COVID Pandemic, KBMO was one of the first commercial labs offering antibody and PCR testing to providers.

Connect